Skip Navigation



Rheumatology Advance Access published online on July 4, 2006

Rheumatology, doi:10.1093/rheumatology/kel200
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
46/1/81    most recent
kel200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gaspersic, N.
Right arrow Articles by Rozman, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaspersic, N.
Right arrow Articles by Rozman, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received January 25, 2006
Accepted May 9, 2006

Original Papers

Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti-{beta}2-glycoprotein I and anti-annexin A5 antibodies

N. Gaspersic 1 *, A. Ambrozic 1, B. Bozic 1, J. Majhenc 2, S. Svetina 2, and B. Rozman 1

1 Department of Rheumatology, University Medical Centre, University of Ljubljana, Ljubljana, Slovenia
2 Institute of Biophysics, School of Medicine, University of Ljubljana, Ljubljana, Slovenia

* To whom correspondence should be addressed.
N. Gaspersic, E-mail: ngaspersic{at}yahoo.com


   Abstract

Objectives. Anti-phospholipid antibodies have been recognized to play a role in vascular thrombosis and pregnancy morbidity. They were first thought to be directed to phospholipids, but it is now known that the majority of pathogenic antibodies recognizes epitopes on phospholipid-binding plasma proteins such as {beta}2-glycoprotein I ({beta}2GPI) or possibly also annexin A5 (ANXA5). The mechanism of their prothrombotic action is still not completely understood. The aim of the present study was to observe the effect of antibodies against ANXA5 (aANXA5) and antibodies against {beta}2GPI (a{beta}2GPI) on the binding of ANXA5 to the negatively charged phospholipid membrane.

Methods. Giant phospholipid vesicles (GPVs) were used as a simple model of the membrane surface. GPVs composed of phosphatidylserine and phosphatidylcholine were produced in an aqueous medium. A single GPV was transferred to the solution containing ANXA5 conjugated with Alexa Fluor 488 (FANXA5) and (i) aANXA5 or a{beta}2GPI and (ii) different concentrations of a{beta}2GPI together with {beta}2GPI. The emission of the fluorescent light from the GPV surface, as the result of FANXA5 binding, was measured.

Results. {beta}2GPI together with a{beta}2GPI reduced the binding of FANXA5 to GPVs. On the contrary, aANXA5 enhanced the binding of ANXA5 to the GPV surface.

Conclusions. Our results point to the competition between FANXA5 and complexes of {beta}2GPI-a{beta}2GPI for the same binding sites and therefore support the hypothesis of the disruption of the ANXA5 protective shield on procoagulant phospholipid surface. The influence of increased cell surface ANXA5 concentration in the presence of aANXA5 on coagulation needs to be further studied.

Keywords: Annexin A5; Anti-annexin A5; Anti-{beta}2-glycoprotein I; Giant phospholipid vesicles.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
The Journal of Rheumatology SupplementHome page
E. SOSCIA, R. SCARPA, M. A. CIMMINO, M. ATTENO, R. PELUSO, C. SIRIGNANO, L. COSTA, S. IERVOLINO, F. CASO, A. DEL PUENTE, et al.
Magnetic Resonance Imaging of Nail Unit in Psoriatic Arthritis
J Rheumatol Suppl, August 1, 2009; 83(0): 42 - 45.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.